Management of Neurologic Diseases
Summary
- Optimal management of patients with CD4+ cell counts < 200 cells/mm3 and negative serum toxoplasmosis antibodies is unclear
- Cerebral toxoplasmosis without detectable serum antibodies is uncommon[Sadler 1998]
- Some clinicians may choose to treat such patients empirically for toxoplasmosis, given the risks of brain biopsy
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: Cancer, IRIS, Neurologic Complications